Comprehensive drug registration, dossier preparation, eCTD submissions, and lifecycle management services — designed to accelerate your path to global market approval.
Medwisdom Lifescience is a leading pharmaceutical regulatory consulting firm with deep expertise in managing every phase of drug, vaccine, and biosimilar product registration. Our team provides end-to-end regulatory support — from early development strategy through post-approval lifecycle management — ensuring your product meets the highest regulatory standards across 15+ global markets.
Whether you are launching a new drug formulation, filing an eCTD dossier, or managing post-approval changes, Medwisdom delivers precise, timely, and cost-effective regulatory solutions tailored to your product category and target regions.
Start Your Regulatory Journey
We cover every stage of the drug product lifecycle — from pre-clinical planning to commercial post-approval management — with proven regulatory methodologies.
Strategic regulatory guidance during early development, defining the optimal pathway for drug, vaccine, or biosimilar approval in target markets.
Meticulous documentation review, dossier formatting, and pre-submission coordination to ensure all filings meet regional health authority requirements.
Systematic identification of compliance gaps against current regulatory standards, followed by a clear remediation roadmap for timely submissions.
High-quality authoring of CTD/eCTD modules, clinical overviews, quality summaries, and risk management plans aligned with ICH guidelines.
End-to-end dossier compilation, technical review, and electronic submission management to health authorities in Europe, Asia, North America, and beyond.
Prompt, scientifically robust responses to regulatory authority queries and deficiency letters, minimizing review delays and protecting approval timelines.
Regulatory handling of variations, label updates, site changes, and other post-approval submissions across multiple jurisdictions simultaneously.
Continuous regulatory maintenance — renewals, periodic safety updates, pharmacovigilance compliance, and market surveillance throughout the product's commercial life.
Our regulatory consultants combine deep scientific knowledge, regional expertise, and structured processes to deliver efficient, compliant, and cost-optimized outcomes.
We deliver high-value pharmaceutical regulatory support at competitive rates, ensuring no trade-off between quality and cost-efficiency.
From initial development planning to post-market compliance, our team manages every regulatory milestone under one roof.
Specialists with 20+ years of combined expertise in pharmaceuticals, vaccines, biosimilars, and combination products across global markets.
In-depth understanding of EMA, FDA, CDSCO, SFDA, PMDA, and other regulatory frameworks ensures region-tailored strategies that work.
Our consultants engage directly with regulatory bodies to clarify requirements, address queries, and accelerate review and approval timelines.
Proven, structured submission workflows designed to minimize delays, de-risk approvals, and ensure smooth commercial launches in new markets.
A clear, transparent workflow from initial consultation to final market approval — designed for speed, accuracy, and full compliance.
We assess your product, target markets, and regulatory pathway requirements.
We identify compliance gaps and develop a detailed regulatory roadmap.
Our experts author, compile, and review all regulatory documents and modules.
We submit dossiers and liaise directly with health authorities on your behalf.
Post-approval, we manage variations, renewals, and ongoing compliance.
Have questions? Our team is ready to help you navigate the regulatory landscape with confidence.
Partner with Medwisdom Lifescience for expert, end-to-end pharmaceutical regulatory consulting. Let us simplify compliance so you can focus on bringing life-saving products to market faster.